AQP4 and glioblastoma: The therapeutic significance of AQP4 has prompted the investigation of the intersection between glioblastoma and NMOSD, an autoimmune condition characterized by the presence of pathogenic anti-AQP4 antibodies (Castañeyra-Ruiz et al., 2014).